Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia
Clinical trial NCT03593213 · TERMINATED
Trial details
- NCT number
- NCT03593213
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-30
- Primary completion
- 2021-02-11
- Enrollment
- 587
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.